An observational cohort study evaluating effectiveness and safety of tenofovir alafenamide based regimen in HIV infected patients

Trial Profile

An observational cohort study evaluating effectiveness and safety of tenofovir alafenamide based regimen in HIV infected patients

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 27 Oct 2017

At a glance

  • Drugs Cobicistat/elvitegravir/emtricitabine/tenofovir alafenamide (Primary)
  • Indications HIV infections; HIV-1 infections
  • Focus Adverse reactions; Therapeutic Use
  • Acronyms TAFNES
  • Most Recent Events

    • 27 Oct 2017 Interim results assessed at month-12 (n=265; as of 27 April 2017) presented at the 16th European AIDS Conference
    • 30 Dec 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top